We are a certified pharmaceutical company offering exclusive franchise opportunities for injection manufacturing, with special authorization for Allizone-S 1.5/375 production. Our ...

We are a certified pharmaceutical company offering exclusive franchise opportunities for injection manufacturing, with special authorization for Allizone-S 1.5/375 production. Our organization holds complete production authority for this medication range, ensuring authentic, quality-assured injectables for serious business partners. The injections combine Ceftriaxone and Sulbactam in precise formulations, available in both dry powder and aqueous solutions. Dry formulations require proper dilution with sterilized distilled water following established medical protocols. This partnership model is designed for distributors, importers, and wholesalers seeking reliable manufacturing with full regulatory compliance and production legitimacy.

This pharmaceutical franchise serves multiple healthcare sectors including hospital supply networks, medical wholesale distributors, clinical facilities, and healthcare providers. The injections are particularly valuable for medical professionals treating bacterial infections, respiratory conditions, surgical complications, and emergency medical cases. Our state-specific franchise approach ensures localized regulatory compliance and distribution efficiency, making it ideal for partners operating in diverse regional markets. The product meets stringent quality standards required by medical institutions and healthcare systems, maintaining consistent therapeutic efficacy across all batches.

Business value is delivered through guaranteed product reliability, consistent supply chain performance, and comprehensive franchise support. Our differentiators include unique quality control processes, production authority for specialized formulations, and adaptability to regional regulatory requirements. Partners benefit from our authorized manufacturing status which streamlines regulatory compliance and enhances market credibility. The franchise model ensures that distributors receive genuine products with verified therapeutic efficacy, supporting their professional reputation in competitive pharmaceutical markets. We prioritize sustainable partnerships through transparent operations and unwavering commitment to product quality and patient safety.

Key Features:
- Authorized production of Allizone-S 1.5/375 with complete manufacturing rights
- Available in both dry powder and ready-to-use aqueous injection formulations
- Precise combination of Ceftriaxone and Sulbactam in therapeutic ratios
- Franchise opportunities covering multiple state territories
- Requires proper dilution with sterilized distilled water as per medical guidelines

Benefits:
- Guaranteed product authenticity and therapeutic reliability for healthcare providers
- Consistent supply chain performance with quality-assured manufacturing processes
- Enhanced market credibility through authorized production status and compliance
- Streamlined regulatory approvals and documentation for franchise partners
- Professional reputation building through verified product efficacy and safety